Paul H. is a seasoned Drug/Vaccine Supply Chain Consultant at Tunnell Consulting, Inc., where he plays a pivotal role in supporting the U.S. Department of Health and Human Services (HHS), particularly within the Biomedical Advanced Research and Development Authority (BARDA) and the Pandemic Preparedness Influenza...
Paul H. is a seasoned Drug/Vaccine Supply Chain Consultant at Tunnell Consulting, Inc., where he plays a pivotal role in supporting the U.S. Department of Health and Human Services (HHS), particularly within the Biomedical Advanced Research and Development Authority (BARDA) and the Pandemic Preparedness Influenza and Emerging Diseases (PCI) programs. With a robust background in supply chain leadership, Paul leverages his diverse industry experience to enhance operational efficiencies and drive innovative solutions in the face of public health challenges.
Currently, Paul is deeply involved in critical projects aimed at bolstering the nation’s pandemic preparedness capabilities. His expertise is particularly evident in his contributions to the SARS-CoV-2 pandemic response, where he served as a Person in the Plant (PIP) for several drug product manufacturers. In this capacity, he provided invaluable on-site support to ensure that vaccine production met stringent quality and regulatory standards, facilitating timely delivery to the market. His work extends to managing supply chain logistics for emerging disease programs, including those addressing Marburg, Ebola, and Monkeypox, where he applies Lean Six Sigma methodologies to streamline processes and enhance supply chain performance.
Paul’s skill set encompasses materials management, project management, and ERP systems, with a strong focus on performance metrics and collaborative working. His ability to foster cross-functional teamwork is instrumental in driving new product launches and improving global supply chain dynamics. By combining his business acumen with a disciplined approach to continuous improvement, Paul is dedicated to advancing public health initiatives and ensuring that the supply chain is resilient and responsive to future challenges.
